Australia Medical Cannabis Market, by Distribution Channel

Growth Outlook

• The Australia Medical Cannabis Market, by Distribution Channel market is on a steady long-term growth path. Segment value stands at roughly USD 1220 Mn in 2026 and is projected to reach USD 1471 Mn by 2027 — a gain of about 21% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Hospital pharmacy leads, holding roughly 56% of segment value — the single largest regional share. Retail Pharamcy is the second-largest contributor. Online Pharmacy make up the remainder, in descending order.
• By 2027, Hospital pharmacy alone is expected to reach USD 821 Mn, with Retail Pharamcy at USD 420 Mn.

Market Dynamics

The demand for medical cannabis in Australia has been steadily increasing in recent years, driven by growing awareness of its potential therapeutic benefits and changes in legislation allowing for legal access to the drug for certain medical conditions. With this increase in demand, the market for medical cannabis in Australia is experiencing significant growth, particularly in the distribution channel space.

One of the most important factors contributing to the demand for medical cannabis in Australia is the changing attitude towards the drug. In the past, cannabis was largely stigmatized and associated with recreational drug use. However, with more research and evidence emerging about its potential medicinal properties, attitudes have shifted and acceptance towards medical cannabis has grown. This has led to an increase in patient demand and a drive towards easier access to the drug through different distribution channels.

One of the major distribution channels for medical cannabis in Australia is through pharmacies. As the main source of prescription medicines in the country, pharmacies play a critical role in the distribution of medical cannabis. With the recent legal changes allowing for prescription and use of cannabis for medical purposes, pharmacies have become an essential gateway for patients to access the drug. Pharmaceutical companies have also started to develop and distribute medical cannabis products specifically targeting this market, further driving the demand through pharmacies.

Another key distribution channel for medical cannabis in Australia is through online platforms. The rise of e-commerce in the country has made it easier for patients to purchase medical cannabis products without having to physically visit a pharmacy. This also provides a discreet option for individuals who may not feel comfortable purchasing the drug in person. Additionally, online platforms offer a wider selection of products and brands, enabling patients to find the specific type of medical cannabis that best suits their needs.

The demand for medical cannabis is also driving the growth of specialized clinics and dispensaries across the country. These facilities provide a more comprehensive approach to prescribing and managing medical cannabis for patients. By offering a range of distribution options, including consultations and follow-up visits with healthcare professionals, they provide a more personalized experience for patients and drive demand for medical cannabis products.

In conclusion, the demand for medical cannabis in Australia is rapidly growing, with various distribution channels playing a crucial role in meeting this demand. As attitudes continue to shift and legislation becomes more supportive, it is expected that the medical cannabis market in Australia will continue to expand and evolve in the coming years.